AngioDynamics (FRA:UG2) EPS (Basic): €-0.65 (TTM As of Feb. 2026)

What is AngioDynamics EPS (Basic)?

AngioDynamics FRA:UG2 -0.92% 62 EPS (Basic) is €-0.65 as of Feb. 2026. GuruFocus rates FRA:UG2 with a GF Score™ of 62/100 and a GF Value™ of €7.27. The stock has 7 warning signs investors should review.

AngioDynamics's basic earnings per share (Basic EPS) for the three months ended in Feb. 2026 was €-0.16. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Feb. 2026 was €-0.65.

AngioDynamics's EPS (Diluted) for the three months ended in Feb. 2026 was €-0.16. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 was €-0.65.

AngioDynamics's EPS without NRI for the three months ended in Feb. 2026 was €0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Feb. 2026 was -0.15.

During the past 3 years, the average EPS without NRI Growth Rate was 30.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, AngioDynamics's highest 3-Year average EPS without NRI Growth Rate was 100.00% per year. The lowest was -59.30% per year. And the median was 8.50% per year.

AngioDynamics (FRA:UG2) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

AngioDynamics EPS (Basic) Related Terms

AngioDynamics EPS (Basic) Historical Data

* Premium members only.

The historical data trend for AngioDynamics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics EPS (Basic) Chart

AngioDynamics Annual Data

Trend

May16

May17

May18

May19

May20

May21

May22

May23

May24

May25

EPS (Basic)

Get a 7-Day Free Trial

-0.68

-0.64

-1.22

-4.25

-0.74

AngioDynamics Quarterly Data
	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25	Feb26
EPS (Basic)	Get a 7-Day Free Trial															-0.11	-0.13	-0.22	-0.13	-0.16

62GF Score

AngioDynamics Inc FRA:UG2

EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

AngioDynamics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

AngioDynamics's Basic EPS for the fiscal year that ended in May. 2025 is calculated as

Basic EPS (A: May. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-30.152	-	0)	/	40.853
	=	-0.74

AngioDynamics's Basic EPS for the quarter that ended in Feb. 2026 is calculated as

Basic EPS (Q: Feb. 2026 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-6.839	-	0)	/	41.596
	=	-0.16

EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.65

Frequently Asked Questions Learn more about EPS (Basic) →

What does a EPS (Basic) of €-0.65 mean?

AngioDynamics (FRA:UG2) has a EPS (Basic) of €-0.65 as of Feb. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on AngioDynamics and its competitors.

Is AngioDynamics' EPS (Basic) too high?

AngioDynamics' current EPS (Basic) is €-0.65. Overall, AngioDynamics has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.

How does AngioDynamics' EPS (Basic) compare to OSUR and UTMD?

AngioDynamics' EPS (Basic) of €-0.65 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EPS (Basic) for a Medical Devices & Instruments company?

A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EPS (Basic) mean?

A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on AngioDynamics and its competitors. AngioDynamics's current EPS (Basic) is €-0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is AngioDynamics stock overvalued right now?

AngioDynamics (FRA:UG2) has a current EPS (Basic) of €-0.65. The stock's GF Value™ is €7.27, compared to a current price of €10.80 — trading 48.6% above its estimated fair value. The current EPS (Basic) is €-0.65. AngioDynamics' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EPS (Basic) calculated?

EPS (Basic) is calculated from a company's financial statements. For AngioDynamics (FRA:UG2), the current EPS (Basic) is €-0.65 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AngioDynamics (FRA:UG2) Overvalued in 2026?

Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued. The current stock price of €10.80 is trading 48.6% above its estimated GF Value™ of €7.27.

Key valuation signals for FRA:UG2:

EPS (Basic): €-0.65
GF Value™: €7.27 vs. price of €10.80 (48.6% above fair value)
GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the FRA:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AngioDynamics Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OSUR UTMD SMTI PDEX EMBC STXS KRMD MBOT DXR POCI ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges ANGO:USA

Address 14 Plaza Drive, Latham, NY, USA, 12110

Website https://www.angiodynamics.com

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

62GF Score

Get the complete analysis for FRA:UG2

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80

Price

€7.27

GF Value

View FRA:UG2 Analysis

See EPS (Basic) data for all stocks →